These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14687724)

  • 1. A dual role for tumor-derived chemokine RANTES (CCL5).
    Adler EP; Lemken CA; Katchen NS; Kurt RA
    Immunol Lett; 2003 Dec; 90(2-3):187-94. PubMed ID: 14687724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived CCL5 does not contribute to breast cancer progression.
    Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
    Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma.
    Li J; Liu H; Li L; Wu H; Wang C; Yan Z; Wang Y; Su C; Jin H; Zhou F; Wu M; Qian Q
    Oncol Rep; 2013 Mar; 29(3):895-902. PubMed ID: 23292657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor-derived CCL2 on T cell effector function.
    Vitiello PF; Shainheit MG; Allison EM; Adler EP; Kurt RA
    Immunol Lett; 2004 Feb; 91(2-3):239-45. PubMed ID: 15019295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.
    Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N
    Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.
    Fischer M; Juremalm M; Olsson N; Backlin C; Sundström C; Nilsson K; Enblad G; Nilsson G
    Int J Cancer; 2003 Nov; 107(2):197-201. PubMed ID: 12949794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
    Pevida M; Lastra A; Meana Á; Hidalgo A; Baamonde A; Menéndez L
    Neuroscience; 2014 Feb; 259():113-25. PubMed ID: 24316469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.
    Swamydas M; Ricci K; Rego SL; Dréau D
    Cell Adh Migr; 2013; 7(3):315-24. PubMed ID: 23722213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations.
    Mulé JJ; Custer M; Averbook B; Yang JC; Weber JS; Goeddel DV; Rosenberg SA; Schall TJ
    Hum Gene Ther; 1996 Aug; 7(13):1545-53. PubMed ID: 8864755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
    Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
    Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.
    Zhang Y; Lv D; Kim HJ; Kurt RA; Bu W; Li Y; Ma X
    Cell Res; 2013 Mar; 23(3):394-408. PubMed ID: 23266888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
    Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
    Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.
    Dénes A; Humphreys N; Lane TE; Grencis R; Rothwell N
    J Neurosci; 2010 Jul; 30(30):10086-95. PubMed ID: 20668193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.
    Liu J; Li F; Ping Y; Wang L; Chen X; Wang D; Cao L; Zhao S; Li B; Kalinski P; Thorne SH; Zhang B; Zhang Y
    Oncotarget; 2015 Sep; 6(28):24978-89. PubMed ID: 26317795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
    Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
    Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
    Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
    Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.